Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:141-146
doi: 10.1161/hq0102.101097
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paultre, F.
Right arrow Articles by Berglund, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paultre, F.
Right arrow Articles by Berglund, L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Carotid Artery Disease
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Risk Factors
Right arrow Other arteriosclerosis
Right arrow Risk Factors for Stroke
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:141.)
© 2002 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Relation of Apo(a) Size to Carotid Atherosclerosis in an Elderly Multiethnic Population

Furcy Paultre; Catherine H. Tuck; Bernadette Boden-Albala; Douglas E. Kargman; Elizabeth Todd; Jeffrey Jones; Myunghee C. Paik; Ralph L. Sacco; Lars Berglund

From the Departments of Medicine (F.P., C.H.T., E.T., J.J., L.B.), Neurology (B.B.-A., D.E.K., R.L.S.), Biostatistics (M.C.P.), Epidemiology (B.B.-A., D.E.K., R.L.S.), and Socio-Medical Sciences (B.B.-A.), Columbia University, New York, NY.

Correspondence to Lars Berglund, MD, PhD, Department of Medicine, Columbia University, PH 10-305, 630 West 168th St, New York, NY 10032. E-mail lfb9{at}columbia.edu

Lipoprotein(a) [Lp(a)] is a novel risk factor for atherosclerosis, whose role in multiracial populations has been debated. We recently demonstrated a significant association of elevated levels of Lp(a) carried in particles containing small apolipoprotein(a) [apo(a)] isoforms with coronary artery disease in African American and white men. To extend these findings, we investigated the associations between Lp(a) levels, apo(a) size, and maximum internal carotid artery plaque thickness (MPT) in a randomly selected elderly multiethnic population (173 men and 253 women, consisting of 135 African Americans, 146 Hispanics, and 145 whites; mean age 70.5±11.4 years). Lp(a) levels were not associated with MPT. Among white men, MPT was associated with a small apo(a) isoform size (P=0.03) as well as with the amount of Lp(a) carrying the small apo(a) size (P=0.04), and the latter showed a borderline association in African American men (P=0.07). Among white women, but not in Hispanic or African American women, MPT was associated with the amount of Lp(a) carrying a small apo(a) isoform size (P<0.01). For all patients, the amount of Lp(a) carrying the small apo(a) size was associated with carotid atherosclerosis when there was control for age, sex, ethnicity, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, diabetes mellitus, hypertension, waist-to-hip ratio, and current smoking status (P=0.03). This association was significant for all men (P=0.03) and for white women (P=0.007). The results suggest that molecular properties of apo(a) are important in determining the atherogenicity of Lp(a).


Key Words: lipoprotein(a) • carotid arteries • risk factors • African American • Hispanic




This article has been cited by other articles:


Home page
Arch NeurolHome page
J. Z. Willey, Q. Xu, B. Boden-Albala, M. C. Paik, Y. P. Moon, R. L. Sacco, and M. S. V. Elkind
Lipid Profile Components and Risk of Ischemic Stroke: The Northern Manhattan Study (NOMAS)
Arch Neurol, November 1, 2009; 66(11): 1400 - 1406.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Anuurad, J. Rubin, A. Chiem, R. P. Tracy, T. A. Pearson, and L. Berglund
High Levels of Inflammatory Biomarkers Are Associated with Increased Allele-Specific Apolipoprotein(a) Levels in African-Americans
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1482 - 1488.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Berglund and R. Ramakrishnan
Lipoprotein(a): An Elusive Cardiovascular Risk Factor
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2219 - 2226.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. F. Arenillas, C. A. Molina, P. Chacon, A. Rovira, J. Montaner, P. Coscojuela, E. Sanchez, M. Quintana, and J. Alvarez-Sabin
High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis
Neurology, July 13, 2004; 63(1): 27 - 32.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. D. Wu, L. Berglund, C. Dimayuga, J. Jones, R. R. Sciacca, M. R. Di Tullio, and S. Homma
High lipoprotein(a) levels and small apolipoprotein(a) sizes are associated with endothelial dysfunction in a multiethnic cohort
J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1828 - 1833.
[Abstract] [Full Text] [PDF]